1Kawasuji M. Nagamine H, Ikeda M, et al. Therapeutic angiogene sis with intramyocardial administration of basic fibrolast growth factor[J]. Ann Thorac Surg ,2000 , 69 ( 4 ) :115-1161.
2Unger E F, Goncalves L, Epstein S E, et al. Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris[J]. Am J Cardiol,2000,85(12 ) :1414-1419.
3Lee L Y, Patel S R, Hackett N R, et al. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121 [ J ]. Ann Thprac Surg, 2000,69( 1 ) : 14-23.
4Mousa A. Mechanisms of angiogenesis in vascular disorders: Potential therapeutic targets[J]. Drugs Fut,1998,23( 1 ) :51-60.
6PARRISH A B, FREEL C D, KORNBLUTH S. Cellular mechanismscontrolling caspase activation and function[J]. Cold Spring HarbPerspect Biol,2013,5:a008672.
7SATO T, MACHIDA T, TAKAHASHI S, et al. Fas-mediatedapoptosomeformation is dependent on reactive oxygen species derived frommitochondrial permeability transition in Jurkat cells[J]. JImmunol,2004,173(1):285-296.
8HOWELLS C C, BAUMANN W T, SAMUELS D C. The Bcl-2-associateddeath promoter (BAD) lowers the threshold at which the Bcl-2-interacting domain death agonist (BID) triggers mitochondriadisintegration[J]. J Biol Chem,2011,271(1):114-123.
9Thomas B. Kryston,Anastassiya B. Georgiev,Polycarpos Pissis,Alexandros G. Georgakilas.??Role of oxidative stress and DNA damage in human carcinogenesis(J)Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis . 2011 (1-2)
10Li Ying-Dong,Ma Yan-Hua,Zhao Jian-Xiong,Zhao Xin-Ke.Protection of ultra-filtration extract from Danggui Buxue Decoction on oxidative damage in cardiomyocytes of neonatal rats and its mechanism. Chinese journal of integrative medicine . 2011
